Collaborative innovation
aims to strengthen early disease monitoring, clinical decision-making, and
remote respiratory care
Sehore: Researchers at VIT
Bhopal University and collaborating institutions have developed an intelligent
remote monitoring system designed to support the continuous assessment of
pulmonary fibrosis, a progressive and debilitating lung disease that often
requires long-term monitoring to track its progression and optimise treatment.
The innovation has been granted an Indian Utility Patent, marking a significant
step in the University's efforts to develop technology-led solutions for
pressing healthcare challenges.
Pulmonary fibrosis causes
irreversible scarring of lung tissue, making breathing increasingly difficult
and significantly affecting patients' quality of life. Monitoring the disease
remains a challenge, as clinicians often rely on periodic hospital visits and
clinical assessments to evaluate disease progression and treatment response.
To address this gap, researchers
from VIT Bhopal, and collaborating institutions have developed the "Apparatus
for Dynamic Monitoring and Analysis in Pulmonary Fibrosis," an
intelligent system designed to continuously acquire and analyse patient-related
clinical data. The technology aims to help healthcare professionals monitor
disease progression in real time, support earlier clinical intervention,
optimise treatment strategies, and enable more personalised, data-driven
management of patients.
The innovation has been granted
under Indian Patent No. 588547, based on Patent Application No. 202421039574,
filed on 21 May 2024 and granted on 7 May 2026.
The patented technology was
developed by Dr. Rajneesh Kumar Patel and Dr. Siddharth Singh Chouhan from the
School of Computer Science and Engineering, VIT Bhopal University, in
collaboration with Dr. Nancy Kumari, a former researcher at VIT Bhopal and currently
at SRM University Delhi-NCR, Dr. Krishna Kumar Pandey from NIT Agartala, Amit
Patel and Sunil Kumar Gautam from MANIT Bhopal.
Designed with future-ready
healthcare ecosystems in mind, the system has potential applications across
continuous patient monitoring, clinical decision support, remote healthcare
delivery, telemedicine, treatment evaluation, respiratory disease research, and
personalised pulmonary care. By enabling longitudinal analysis of patient data,
the technology seeks to support clinicians with timely insights that can
improve long-term disease management.
On the innovation, Ms.
Kadhambari S. Viswanathan, Assistant Vice President, VIT Bhopal University,
said, “This patent is a strong validation of the interdisciplinary research
culture we are building at VIT Bhopal. Pulmonary fibrosis remains a difficult
disease to track and manage, and by giving clinicians a system that
continuously monitors and analyses patient data, our researchers are addressing
a genuine gap in respiratory care. Kudos to the team of researchers who
collaborated for bringing this innovation to the fore.”
From the research team, Dr.
Rajneesh Kumar Patel said, "Pulmonary fibrosis is a complex disease
that demands continuous monitoring to understand how a patient's condition
evolves over time. Our objective was to develop an intelligent system that can
assist clinicians by analysing patient data dynamically, supporting timely
interventions and more informed treatment decisions. We hope this technology
will contribute to the future of connected and personalised respiratory
care."
The patent adds to VIT Bhopal
University's growing portfolio of intellectual property and reinforces its
focus on translating academic research into impactful technologies with
real-world applications. Through sustained investments in research, innovation,
and interdisciplinary collaboration, the University continues to develop
solutions that bridge engineering and healthcare while contributing to India's
vision of becoming a global hub for science, technology, and innovation.